1+ week, 2+ day ago   (653+ words) EMJ This site is intended for healthcare professionals Félix Guerrero-Ramos on Bladder Cancer Advances Félix Guerrero-Ramos | Oncologic Urology Unit Coordinator, Department of Urology, Hospital Universitario 12 de Octubre, Madrid; Co-founder, Danae Urogenomics, Madrid, Spain What first drew you to uro-oncology and,…...

1+ week, 4+ day ago   (324+ words) The study included patients from 55 sites across eight countries between 2015 and 2025. Participants had been diagnosed with prostate cancer within the previous 12 months, had recently started androgen deprivation therapy (ADT), or were due to begin ADT. Patients were randomly assigned to…...

1+ week, 5+ day ago   (461+ words) EMJ This site is intended for healthcare professionals The Future of Gynaecologic Cancer Care with Bhavana Pothuri Bhavana Pothuri: Department of Obstetrics and Gynecology and Medicine, Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, New York, USA…...

2+ week, 2+ day ago   (230+ words) The study evaluated relative leukocyte telomere length (LTL) and gut microbiome profiles among 244 participants with PDAC, chronic pancreatitis (CP), type 2 diabetes mellitus (T2DM), or no related risk conditions. The cohort included 37 patients with PDAC, 56 with CP, 99 with T2DM, and 52 controls. Relative LTL…...

2+ week, 2+ day ago   (220+ words) Before the first BCG treatment, 23 of 57 patients (40%) tested positive for utDNA. Patients with positive results had a 12-month recurrence-free survival of 61%, compared with 85% among those who tested negative (hazard ratio: 3.2; p=0.04). The researchers also assessed utDNA following BCG treatment. Among…...

2+ week, 5+ day ago   (346+ words) A MULTICENTRE retrospective study of 685 patients with unresectable hepatocellular carcinoma (uHCC) found that progressive disease (PD) was the leading reason for discontinuation of atezolizumab plus bevacizumab, while older age and poorer liver function identified patients at greater risk of toxicity-related…...

2+ week, 6+ day ago   (169+ words) EMJ This site is intended for healthcare professionals TOURMALINE: Safety and Efficacy of Durvalumab in Combination with Gemcitabine-Based Chemotherapy in Advanced Biliary Tract Cancer This infographic and the studies discussed were funded by AstraZeneca. This content is intended for US…...

3+ week, 11+ hour ago   (284+ words) A PERSONALIZED mRNA cancer therapy improved recurrence and metastasis outcomes after melanoma surgery in a Phase III trial. These topline findings represent the first positive Phase III results reported for an individualized neoantigen therapy and an mRNA-based cancer treatment. However,…...

3+ week, 1+ day ago   (340+ words) Adult survivors of Hodgkin lymphoma had nearly twice the mortality of the general United States population, according to a population-based retrospective cohort study of 20,057 long-term survivors. The analysis examined adults aged 20 years or older who were diagnosed with a first…...

3+ week, 3+ day ago   (385+ words) EMJ This site is intended for healthcare professionals Moderna mRNA Cancer Vaccine Evaluated in High-Risk Melanoma - The Phase 3 INTerpath-001 trial evaluates intismeran autogene combined with pembrolizumab. - Targeted neoantigen therapy aims to improve recurrence-free survival in resected melanoma. - Adjuvant mRNA vaccination…...